RecruitingNot ApplicableNCT07112651

Efficacy of CL25216 on Vasomotor Symptoms in Women During Perimenopause

The Effects of CL25216 on Vasomotor Symptoms in Women During Perimenopause: a Randomised, Double-blind, Placebo-controlled Study

Sponsor

ApexCPG LLC

Enrollment

80 participants

Start Date

Nov 24, 2025

Study Type

INTERVENTIONAL

Conditions

Vasomotor Symptoms

Summary

This study is to evaluate the effects of CL25216 on vasomotor symptoms in women during Perimenopause. Enrolled subjects will receive either CL25216 - 250 mg/day or placebo.

Eligibility

Sex: FEMALEMin Age: 40 YearsMax Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying CL25216 and Placebo for people with vasomotor symptoms. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 40 Years to 55 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTCL25216

250mg to take one capsule a day after breakfast for 105 days

DIETARY_SUPPLEMENTPlacebo

One capsule a day after breakfast for 105 days

Locations(1)

Shree Hospitals

Vijayawada, India

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07112651

Related Trials

Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy

NCT069576911 location

Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture

NCT073352241 location

JDS-HF3.0 Supplementation on Menopause Related Quality of Life Outcomes in Postmenopausal Women

NCT072384781 location

Safety and Efficacy of Asimadoline (TP0052) in Patients With Vasomotor Symptoms (VMS).

NCT070425161 location

Nurse-led Primary Healthcare Intervention Model in Women's Health Management in Hong Kong

NCT066283883 locations